Akso Health Group (AHG)

Financial Services | Financial Credit Services
Income Statement (Quarterly) 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue 760,377 760,377 446,792 446,792
Cost of Revenue 718,726 718,726 427,377 427,377
Gross Profit 41,651 41,651 19,415 19,415
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 3,202,747 3,202,747 1,177,339 1,177,339
Operating Expenses 3,202,747 3,068,213 1,538,749 1,538,749
Operating Income -3,161,096 -3,161,096 -1,157,924 -1,157,924
Interest Expense 0 0 0 0
Income Before Tax -3,026,562 -3,026,562 -1,519,334 -1,519,334
Income Tax Expense 59 59 12,435 12,435
Net Income -3,000,563 -2,997,405 -1,532,088 -1,532,088
Per Share
EPS -0.14 -0.14 -0.20 -0.20
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Revenue 14,777,798 2,414,338 13,181,561 6,311,092 1,754,935
Cost of Revenue 15,059,324 2,292,206 11,912,571 5,394,866 544,572
Gross Profit -281,526 122,132 1,268,990 916,226 1,210,363
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 3,641,446 8,760,172 15,535,843 15,628,656 28,360,090
Operating Expenses 166,022,826 8,760,172 15,535,843 16,049,842 28,360,090
Operating Income -166,304,352 -8,638,040 -14,266,853 -15,133,616 -30,904,348
Interest Expense 0 0 0 804,138 2,154,621
Income Before Tax -166,270,279 -9,091,791 -13,066,489 -16,718,300 -31,069,266
Income Tax Expense -30,801,146 24,988 17,549 131,433 482,976
Net Income -134,977,369 -9,458,784 -13,084,038 -16,849,733 -34,826,989
Per Share
EPS -0.48 -0.63 -1.71 -0.85 -0.71
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Assets
Cash and Cash Equivalents 176,229,874 85,174,017 7,924,468 21,925,322
Short Term Investments 0 0 0 0
Net Receivables 12,895,578 0 9,498,030 20,017,302
Inventory 190,242 191,201 1,686,449 7,795,822
Total Current Assets 196,124,892 142,018,117 20,732,428 50,624,351
Property Plant Equipment 114,544 0 0 55,433
Goodwill and Intangibles 18,713,889 0 0 0
Total Assets 214,953,325 142,018,117 20,460,299 50,679,784
Liabilities
Account Payables 0 0 -9,686,152 0
Short Term Debt 40,058 0 9,686,152 0
Total Current Liabilities 13,812,907 3,593,923 11,620,783 38,394,202
Long Term Debt 41,679 0 194,376 0
Total Liabilities 15,802,189 3,593,923 11,620,783 38,394,202
Shareholders Equity
Retained Earnings -198,903,752 -63,926,383 -54,467,600 -53,107,676
Total Shareholders Equity 199,119,145 138,367,384 8,725,304 12,283,606
Balance Sheet (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Assets
Cash and Cash Equivalents 176,229,874 85,174,017 7,924,468 21,925,322 15,128,719
Short Term Investments 0 0 0 0 0
Net Receivables 12,895,578 0 9,498,030 20,017,302 14,400,991
Inventory 190,242 191,201 1,686,449 7,795,822 0
Total Current Assets 196,124,892 142,018,117 20,732,428 50,624,351 30,122,488
Property Plant Equipment 114,544 0 0 55,433 66,887
Goodwill and Intangibles 18,713,889 0 0 0 0
Total Assets 214,953,325 142,018,117 20,460,299 50,679,784 31,685,496
Liabilities
Account Payables 0 0 -9,686,152 0 0
Short Term Debt 40,058 0 9,686,152 0 10,000,000
Total Current Liabilities 13,812,907 3,593,923 11,620,783 38,394,202 14,413,971
Long Term Debt 41,679 0 194,376 0 0
Total Liabilities 15,802,189 3,593,923 11,620,783 38,394,202 14,413,971
Shareholders Equity
Retained Earnings -198,903,752 -63,926,383 -54,467,600 -53,107,676 -36,256,612
Total Shareholders Equity 199,119,145 138,367,384 8,725,304 12,283,606 17,271,525
Cash Flow Statement (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Activities
Net Income -135,469,133 -9,116,779 -13,084,038 -16,849,733
Depreciation & Amortization 2,149,790 0 0 18,390
Stock Based Compensation 0 0 0 391,625
Change in Working Capital 3,018,202 2,056,439 -1,173,070 -2,564,152
Operating Cash Flow 1,177,163 1,351,240 -3,253,340 -8,628,371
Investing Activities
Capital Expenditure -154,460 0 0 -4,861
Investments -154,460 0 0 -4,861
Investing Cash Flow -105,912,692 -54,721,082 18,471,082 -19,963,860
Financing Activities
Debt Repayment 0 0 -27,513,848 -10,000,000
Common Stock Issued/Repurchased 195,884,024 139,339,849 0 10,017,200
Dividends Paid 0 0 0 0
Financing Cash Flow 195,884,024 131,653,697 -27,513,848 34,781,117
Summary
Free Cash Flow 1,022,703 1,351,240 -3,253,340 -8,633,232
Net Change in Cash 90,025,480 77,011,691 -12,732,619 6,796,603
Cash Flow Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Operating Activities
Net Income -135,469,133 -9,116,779 -13,084,038 -16,849,733 -34,826,989
Depreciation & Amortization 2,149,790 0 0 18,390 15,161
Stock Based Compensation 0 0 0 391,625 55,468
Change in Working Capital 3,018,202 2,056,439 -1,173,070 -2,564,152 21,111,090
Operating Cash Flow 1,177,163 1,351,240 -3,253,340 -8,628,371 10,058,470
Investing Activities
Capital Expenditure -154,460 0 0 -4,861 0
Investments -154,460 0 0 -4,861 0
Investing Cash Flow -105,912,692 -54,721,082 18,471,082 -19,963,860 -662
Financing Activities
Debt Repayment 0 0 -27,513,848 -10,000,000 -10,000,000
Common Stock Issued/Repurchased 195,884,024 139,339,849 0 10,017,200 0
Dividends Paid 0 0 0 0 0
Financing Cash Flow 195,884,024 131,653,697 -27,513,848 34,781,117 -9,037,223
Summary
Free Cash Flow 1,022,703 1,351,240 -3,253,340 -8,633,232 10,058,470
Net Change in Cash 90,025,480 77,011,691 -12,732,619 6,796,603 4,203,511